RP
CRL icon

Reinhart Partners’s Charles River Laboratories CRL Stock Holding History

Reinhart Partners’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-48,742
Closed -$7.34M – 77
2025
Q1 		$7.34M Sell
48,742
-1,934
-4% -$324K 0.27% 66
2024
Q4 		$9.35M Sell
50,676
-11,822
-19% -$2.28M 0.36% 60
2024
Q3 		$12.3M Sell
62,498
-4,547
-7% -$945K 0.47% 54
2024
Q2 		$13.9M Sell
67,045
-4,779
-7% -$1.08M 0.58% 45
2024
Q1 		$19.5M Sell
71,824
-1,071
-1% -$256K 0.79% 39
2023
Q4 		$17.2M Sell
72,895
-16,174
-18% -$3.18M 0.76% 39
2023
Q3 		$17.5M Sell
89,069
-3,954
-4% -$812K 0.91% 41
2023
Q2 		$19.6M Sell
93,023
-433
-0.5% -$86.2K 0.99% 41
2023
Q1 		$18.9M Buy
93,456
+24,952
+36% +$5.65M 1.02% 38
2022
Q4 		$14.9M Buy
68,504
+21,730
+46% +$4.75M 0.81% 57
2022
Q3 		$9.21M Buy
+46,774
New +$10.1M 0.57% 72

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Reinhart Partners's CRL Position: Q2 2025 in Review

Reinhart Partners sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 48,742 shares — an estimated $7.34M sold.

Reinhart Partners first reported a position in CRL in Q3 2022 and held it in 11 quarters. The position peaked at $19.6M in Q2 2023. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • Reinhart Partners reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
  • Reinhart Partners sold 48,742 Charles River Laboratories shares in Q2 2025, an estimated $7.34M.
  • Reinhart Partners first reported a position in Charles River Laboratories in Q3 2022 and held it in 11 quarters.
  • Reinhart Partners's Charles River Laboratories position peaked at $19.6M in Q2 2023.
  • 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on Reinhart Partners's 13F filing for Q2 2025, filed 9 Jul 2025.